Overview

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

Status:
NOT_YET_RECRUITING

Trial end date:
2026-06-14

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of Itraconazole and Rifampin on the drug levels of AR-LDD (BMS-986365) in healthy adult male participants.

Phase:

PHASE1

Details

Lead Sponsor:

Celgene

Treatments:

Itraconazole
Rifampin